hit counter
IRIDEX Corporation (IRIX) Stock News Sentiment & Price - Sentifly
IRIX - Sentifly


Profile

Watchlist

Your watchlist is empty. Go add some tickers to it!



IRIDEX Corporation (IRIX)

USA
Medical Appliances & Equipment
NASDAQ
IRIX Price and Sentiment
1MO
1D
Positive, Negative
Loading chart...
IRIX Latest news
Seeking Alpha
Neutral
IRIDEX Corporation (IRIX) CEO Dave Bruce on Q3 2021 Results - Earnings Call Transcript
2021-11-11 20:30

IRIDEX Corporation (IRIX) CEO Dave Bruce on Q3 2021 Results - Earnings Call Transcript

GlobeNewsWire
Neutral
Iridex Announces Third Quarter 2021 Financial Results
2021-11-11 16:05

Achieved 51% Year-over-Year Revenue Growth and Raises 2021 Revenue Guidance Achieved 51% Year-over-Year Revenue Growth and Raises 2021 Revenue Guidance

Zacks Investment Research
Positive
Iridex (IRIX) Soars 7.3%: Is Further Upside Left in the Stock?
2021-11-08 11:32

Iridex (IRIX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

GlobeNewsWire
Neutral
Retina and Glaucoma Experts Will Present Best Practices Using Iridex Technologies at a Consensus Panel and the AAO Annual Meeting
2021-11-06 12:44

An international expert consensus panel will discuss best practices in dosing and patient selection using MicroPulse TLT on November 6, 2021

Zacks Investment Research
Negative
Earnings Preview: Iridex (IRIX) Q3 Earnings Expected to Decline
2021-11-04 16:47

Iridex (IRIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

InvestorPlace
Positive
The Top 7 Micro-Cap Stocks to Buy Before 2022
2021-11-04 08:50

Micro-cap stocks offer big growth potential, but not all opportunities are created equal. Each of these earns a Portfolio Grader “A” rating.

GlobeNewsWire
Neutral
Iridex to Report Third Quarter 2021 Financial Results on November 11, 2021
2021-10-28 16:05

MOUNTAIN VIEW, Calif., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, today announced the Company will release financial results for the third quarter of 2021 after the close of trading on Thursday, November 11, 2021. The Company's management team will host a corresponding conference call beginning at 2:00 p.m. PT / 5:00 p.m. ET.

Zacks Investment Research
Positive
Is IRIDEX (IRIX) Stock a Solid Choice Right Now?
2021-09-08 10:14

IRIDEX (IRIX) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

Benzinga
Positive
Iridex Stock Gains After Posting Highest Sales Since 2007
2021-08-13 11:37

Iridex Corporation (NASDAQ: IRIX) reported Q2 revenue of $13.4 million, the highest since 2007, +116% Y/Y, beating the consensus of $11.61 million. Cyclo G6 product family generated sales of $3.6 million, +70% Y/Y on 16,000 probes sold, up 103% Y/Y.

Seeking Alpha
Neutral
IRIDEX Corporation (IRIX) CEO Dave Bruce on Q2 2021 Results - Earnings Call Transcript
2021-08-12 23:01

IRIDEX Corporation (IRIX) CEO Dave Bruce on Q2 2021 Results - Earnings Call Transcript

Loading more news...